Brief: Acer Therapeutics Reacquires Worldwide Development, Commercialization & Economic Rights To OLPRUVA From Relief Therapeutics
30/08/2023 22:55
Aug 30 (Reuters) - Acer Therapeutics Inc ACER.O :
* ACER THERAPEUTICS REACQUIRES WORLDWIDE DEVELOPMENT,
COMMERCIALIZATION AND ECONOMIC RIGHTS TO OLPRUVA™ FROM RELIEF
THERAPEUTICS, EXCLUDING THE GEOGRAPHICAL EUROPE
Source text for Eikon: ID:nGNX9GHrdQ
Further company coverage: ACER.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Acer Therapeutics
See all newsBrief: Leading Independent Proxy Advisory Firms Iss And Glass Lewis Recommend Acer Therapeutics Shareholders Vote "For" The Proposed Merger And Related Proposals
U.S. STOCKS ON THE MOVE-UGI, SkyWest, Sage Therapeutics
Acer Therapeutics surges on Zevra buyout deal
Brief: Zevra Therapeutics To Acquire Acer Therapeutics, Expanding Its Rare Disease Portfolio And Adding Commercial Product
Swiss stocks - Factors to watch on August 31